Entering text into the input field will update the search result below

GW Pharma's Cannabinoid-Based Epilepsy Position Continues To Strengthen

Apr. 02, 2018 11:58 AM ETGW Pharmaceuticals plc (GWPH)SKYE17 Comments
Nick Cox profile picture
Nick Cox


  • GW Pharma announce further epilepsy drug patent protection.
  • More indicators of the efficacy of cannabinoids for epilepsy treatment.
  • Nemus could yet become a major player in this space.
  • Childhood Epilepsy solutions are just the first phase in a range of treatments for GW Pharma.

GW Pharma (NASDAQ:GWPH) is undoubtedly at the head of the queue for potential approval of cannabis-based drugs for the treatment of epilepsy. New recent patent issuances have strengthened this position. Developments in Europe further press the argument of the efficacy of cannabinoids for epilepsy conditions. Other companies chasing this elixir all have their disadvantages. Nemus Bioscience remains a possible long-term but high risk play in this field.

Cannabis Oil & Epilepsy.

A recent high profile case in the U.K. has highlighted the efficacious effect of plain cannabis oil on epilepsy. This has been taken up in Parliament following a sign-in campaign and support from high-profile personalities including Patrick Stewart, pictured below outside 10 Downing Street:

Source:Daily Mail

The unfortunate 6-year old in question has a rare form of epilepsy called PCDH19. This can lead to up to 30 seizures a day. Medical psychosis and an early death is the likely result of such a condition.

Cannabis oil is legal in most of Europe but not in the U.K. Five months of treatment in the Netherlands had led to substantial reductions in seizures. However cannabis oil is termed a "banned substance" in the U.K. It is likely the Home Office in England will provide a waiver in this instance under public pressure. It is politically difficult for the Government to hold a position that this boy should suffer and die for lack of cannabis oil.

This case in England is having two big ramifications.

Firstly it is highlighting the apparently general beneficial effects of medical marijuana for certain conditions.

Secondly it is highlighting the specifically beneficial effects of medical marijuana on childhood epilepsy. This suggests that GW Pharma and others are right to think that scientifically produced cannabinoid drugs for the treatment of epilepsy have a big future.

In the USA, 29

This article was written by

Nick Cox profile picture
Nick Cox is a long-time entrepreneur and investor,currently living in Singapore.He has lived and worked in the Asia-Pacifci region for many years.He is a graduate in modern history and economics from University College,London University. His investment strategy is centred around finding long-term growth companies in the region based on inspiring Management and businesses at the cutting edge of new growth areas. Asia is the leading driver of worldwide economic growth today and for the medium term.

Analyst’s Disclosure: I am/we are long GWPH. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.